Skip to main content
. 2018 Feb 14;33(12):e88. doi: 10.3346/jkms.2018.33.e88

Table 3. Clinical characteristics of subjects.

Variables MBAT (n = 21) CONT (n = 23) t2 P value
Physical symptoms
Duration of CAD, yr < 1 2 (40.0) 3 (60.0) 3.283 0.193
1–3 9 (37.5) 15 (62.5)
> 3 10 (66.7) 5 (33.3)
History of MI Yes 2 (33.3) 4 (66.7) 0.577 0.447
No 19 (50.0) 19 (50.0)
PCI Yes 12 (57.1) 9 (42.9) 1.428 0.232
No 9 (39.1) 14 (60.9)
Revascularization Yes 1 (50.0) 1 (50.0) 0.004 0.949
No 20 (47.6) 22 (52.4)
Congestive heart failure Yes 0 (0.0) 1 (100.0) 0.934 0.333
No 21 (48.8) 22 (51.2)
History of stroke Yes 0 (0.0) 1 (100.0) 0.934 0.333
No 21 (48.8) 22 (51.2)
Family history of CAD Yes 14 (45.2) 17 (54.8) 0.277 0.598
No 7 (53.8) 6 (46.2)
Hypercholesterolemia Yes 17 (53.1) 15 (46.9) 1.370 0.241
No 4 (33.3) 8 (66.7)
Hypertension Yes 18 (50.0) 18 (50.0) 0.410 0.521
No 3 (37.5) 5 (62.5)
Diabetes mellitus Yes 4 (44.4) 5 (55.6) 0.049 0.824
No 17 (48.6) 18 (51.4)
Smoking 1.428 0.489
Smoker 6 (42.8) 8 (57.2)
Non-smoker 7 (53.8) 6 (46.2)
Ex-smoker 8 (47.1) 9 (52.9)
Alcohol use 0.820 0.365
Yes 9 (40.9) 13 (59.1)
No 12 (54.5) 10 (45.5)
Risk factors of CAD
Cholesterol, mg/dL 167.52 ± 31.47 160.96 ± 33.98 0.663 0.627
Low-density lipoprotein, mg/dL 95.00 ± 24.72 87.00 ± 25.33 1.058 0.482
High-density lipoprotein, mg/dL 52.67 ± 12.44 52.57 ± 14.54 0.025 0.984
Triglyceride, mg/dL 117.86 ± 75.85 130.87 ± 60.09 −0.634 0.640
Serum creatinine, mg/dL 0.90 ± 0.21 0.97 ± 0.21 −1.167 0.451
Systolic blood pressure, mmHg 131.14 ± 12.13 126.26 ± 7.07 1.649 0.347
Diastolic blood pressure, mmHg 78.81 ± 8.95 79.48 ± 5.19 −0.306 0.811

Values are presented as mean ± SD or number (%).

SD = standard deviation, MBAT = mindfulness-based art therapy, CONT = healthy control group, CAD = coronary artery disease, PCI = percutaneous coronary intervention, MI = myocardial infarction.